New lupus drug candidate enters first human safety tests
NCT ID NCT05411016
First seen Nov 01, 2025 · Last updated Apr 30, 2026 · Updated 19 times
Summary
This early-stage study tests a new drug called KK4277 in healthy volunteers and people with lupus (SLE or CLE). The main goal is to see if the drug is safe and how the body processes it. About 157 participants will receive either the drug or a placebo. This is a first step to see if KK4277 could become a treatment for lupus.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Ajou University Hospital
Suwon, Gyeonggi-do, 16499, South Korea
-
Fujita Health University Hospital
Kutsukake, Aichi-ken, 470-1192, Japan
-
Fukushima Medical University Hospital
Fukushima, 960-1295, Japan
-
Institute of Science Tokyo Hospital
Bunkyō-Ku, Tokyo, 113-8519, Japan
-
Japan Community Health care Organization Chukyo Hospital
Minami, Aichi-ken, 457-8510, Japan
-
Japan Institute for Health Security National Center for Global Health and Medicine
Shinjuku-Ku, Tokyo, 162-8655, Japan
-
Juntendo University Nerima Hospital
Tokyo, 177-8521, Japan
-
Juntendo University Urayasu Hospital
Urayasu, Chiba, 279-0021, Japan
-
Kanazawa University Hospital
Kanazawa, Ishikawa-ken, 920-8641, Japan
-
Keio University Hospital
Shinjuku-Ku, Tokyo, 160-8582, Japan
-
Kitasato University Hospital
Minami, Kanagawa, 252-0375, Japan
-
Kyusyu University Hospital
Higashi, Fukuoka, 812-8582, Japan
-
Medical Co. LTA Sumida Hospital
Sumida-ku, Tokyo, 130-0004, Japan
-
Nagasaki University Hospital
Nagasaki, 852-8501, Japan
-
National University Corporation Tohoku University Tohoku University Hospital
Aoba, Miyagi, 980-8574, Japan
-
Niigata University Medical & Dental Hospital
Chuo Ku, Niigata, 951-8520, Japan
-
Saitama Medical University Hospital
Moriyama, Saitama, 350-0495, Japan
-
Seoul National University Hospital
Seoul, 03080, South Korea
-
Showa Medical University East Hospital
Shinagawa-Ku, Tokyo, 142-0054, Japan
-
St. Luke's International Hospital
Chuo Ku, Tokyo, 104-8560, Japan
-
University of the Ryukyus Hospital
Ginowan, Okinawa, 901-2725, Japan
-
Wakayama Medical University Hospital
Wakayama, 641-8510, Japan
-
Yokohama City University Medical Center
Minami, Kanagawa, 232-0024, Japan
Conditions
Explore the condition pages connected to this study.